Remote auditing was once considered a temporary workaround and an emergency solution to maintain compliance during global disruption. But in 2026, it has cemented itself as a core component of modern quality oversight. The pharmaceutical and medical device industries, along with global regulatory authorities, have embraced hybrid audit models that blend on-site inspections with
Risk-based quality management has been a core expectation in pharmaceutical manufacturing ever since ICH Q9 introduced the concept of integrating science and risk into quality decision-making. However, in 2026, the role of risk-based thinking is undergoing a significant transformation. As digitalisation accelerates and manufacturing processes become more complex, organisations increasingly rely on smart tools,
Discover the key digital and cross-functional skills QA professionals need to thrive in the fast-evolving, technology-driven quality landscape of 2026.
Explore why cross-functional quality skills are now essential in pharma as digitalisation, advanced manufacturing and stricter regulations reshape the industry.
Learn which QA/QC skills pharma employers are prioritising in 2026 as talent shortages grow and regulatory expectations evolve.
Discover how smarter sensors, automation and real-time data are transforming environmental monitoring and strengthening compliance in 2026.
Data-driven validation is transforming process qualification, boosting efficiency, consistency and compliance in modern manufacturing.
Discover how continuous manufacturing is reshaping quality oversight in 2026, improving efficiency, compliance, and real-time product assurance.
Discover how predictive analytics reduces quality risks, boosts efficiency and transforms modern manufacturing through data-driven insights.
Discover how AI-driven deviation management will reshape QA in 2026, from compliance expectations to skills you’ll need to stay ahead.
